Concepedia

Lindy Vernooij

LV

Statistics

Publications

4

Citations

53

H-Index

4

Active since

2020

Affiliations

Princess Máxima Center(Current)

Utrecht University

UNSW Sydney

Lindy Vernooij is an author at Princess Máxima Center specializing in neuroblastoma biology, oncology, and medicine.

ORCID

Publications per year

2020–2025

4

Publications

4

High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells

Lindy Vernooij, Laurel T. Bate-Eya, Lindy K. Alles et al. · Molecular Cancer Therapeutics · 2021 · 19 citations · Full text

, , +14

Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses

Nil A. Schubert, Linda Schild, Stijn van Oirschot et al. · European Journal of Cancer · 2020 · 12 citations · Full text

, , +17

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Thomas F. Eleveld, Lindy Vernooij, Linda Schild et al. · Frontiers in Oncology · 2023 · 11 citations · Full text

, , +17

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

Karin P.S. Langenberg, Sander R. van Hooff, Bianca Koopmans et al. · European Journal of Cancer · 2025 · 11 citations · Full text

, , +17

1–4 of 4